Aprogen Pharmaceuticals Inc (003060) — Free Cash Flow Generation Index
Aprogen Pharmaceuticals Inc (003060) has a Free Cash Flow Generation Index of 0.13x as of December 2022. Free cash flow of ₩85.90 Million represents 0% of operating cash flow (₩676.93 Million). Read total liabilities of Aprogen Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Aprogen Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2022)
Historical FCF Generation Index trend for Aprogen Pharmaceuticals Inc across 7 annual periods. Explore 003060 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year Free Cash Flow Generation Index for Aprogen Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Aprogen Pharmaceuticals Inc.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.94x | ₩24.18 Billion | ₩25.73 Billion | ₩1.55 Billion | ▲ +14.0% |
| 2020 | 0.82x | ₩6.67 Billion | ₩8.09 Billion | ₩976.29 Million | ▲ +134.5% |
| 2019 | -2.39x | ₩-1.71 Billion | ₩713.73 Million | ₩2.13 Billion | ▼ -248.9% |
| 2018 | -0.69x | ₩-912.93 Million | ₩1.33 Billion | ₩1.01 Billion | ▼ -109.4% |
| 2016 | 7.27x | ₩3.27 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +86.0% |
| 2015 | 3.91x | ₩7.22 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -92.3% |
| 2010 | 50.52x | ₩12.52 Billion | ₩247.92 Million | ₩12.28 Billion | — |